Original news and analysis on international IP policy
"Instead of re-hashing old debates about patents, patients and profits, forward-looking pharmaceutical executives should consider new ways of ensuring that medicines reach all patients who need them," writes John Erickson, one of the researchers who discovered the HIV medicine recently licensed by the National Institutes of Health to the Medicines Patent Pool.
A substantive review of a rarely-used amendment to the World Trade Organization intellectual property rules and enforcement trends that may threaten multilateral trade system topped the agenda this week in the Council on Trade-Related Aspects of Intellectual Property Rights (TRIPS).
Daniele Dionisio writes: The current break-through of multinational drug corporations in India couples with the protectionist policies pursued by the US and EU and with India’s obligations as a WTO member. Taken together, these realities mean a heavy threat to India’s freedom as independent provider of lifesaving, affordable and state-of-the-art antiretroviral medicines to the resource-limited countries.
Intellectual property and competition policy are sometimes seen as counterweights, but an efficient patent system and effective competition policy are ultimately complementary in nature, speakers said at an event today at the World Intellectual Property Organization.
NAGOYA, JAPAN - The monumental statue in the courtyard of the Nagoya Congress Center, featuring a warrior on his horse, could be an illustration of the work of the group of officials charged with negotiating a much-anticipated international treaty to protect genetic resources from misappropriation and justly reward provider countries. Meeting over the weekend, they could not find consensus on the text and will have to request another deadline from the United Nations meeting on biodiversity on Monday.
NAGOYA, JAPAN - In weekend attire, delegates in charge of negotiating an international binding instrument protecting countries against misappropriation of their genetic resources arrived at Nagoya Congress Center on Saturday afternoon to take up a new draft text with a day and a half to solve remaining issues.
NAGOYA, JAPAN – Officials negotiating this week on an international agreement to stop misuse of genetic resources appear to have reached minimal consensus on additional articles of the draft text under negotiation, though many specific areas of disagreement were resolved, they said. A Friday deadline for completion was pushed to Monday in the hope they can resolve deeper differences on fundamental issues such as traditional knowledge and compliance.
Several major generic-medicine producing nations last week held a discussion on the dangers of compromised medical products and joined together to urge new steps such as defining terms, focussing on public health and strengthening national regulatory capabilities beyond strictly enforcement actions that they say have been manipulated and at times counterproductive.
NAGOYA, JAPAN - With the clock ticking and less than a day to go before a draft of a legally binding instrument to prevent biopiracy is due to be presented to the assembly of a major United Nations meeting on biodiversity, delegations kept trying to find acceptable language, with different echoes coming from the negotiating room. Meanwhile, Canadian indigenous people convened a press briefing today (21 October) to charge that Canada was trying to block the negotiations and deny their human rights.
NAGOYA, JAPAN - Negotiations on a legal international instrument to prevent biopiracy and ensure that resource holders are compensated on Thursday continued to demand the attention of delegates in the closed-door discussions here. Meanwhile, civil society argued that the Convention on Biological Diversity is at a critical point while a research institute provided a model agreement for providers and users of genetic resources.
Europe has promised at the "highest levels" to fix laws that caused generic medicine seizures in the Netherlands, the Indian Minister of Commerce and Industry said today. The minister is in Geneva for meetings on the ongoing Doha Round trade liberalisation talks at the World Trade Organization.
The World Health Organization has moved responsibility for intellectual property and innovation issues out of the direct control of the WHO director general and into the company of information, evidence and research, according to sources.